Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: Steve Fancy who wrote (3570)	1/9/1998 3:03:00 PM
From: sam	Respond to of 6136

Robbie Stevens just came out with some very bullish comments about AGPH's 4th quarter exceeding expectations.

To: Steve Fancy who wrote (3570)	1/9/1998 3:40:00 PM
From: margie	Read Replies (2) \| Respond to of 6136

Earnings will be released on Monday, January 12. according to Agouron IR. Here are some recent upwards revisions, from Zacks. AGPH: BANCAM/ROB STEP increased estimate for fiscal year ending 06/98 from $0.72 to $0.83 on 01/08/98 AGPH: BANCAM/ROB STEP increased estimate for fiscal year ending 06/99 from $1.15 to $1.18 on 01/08/98 AGPH: BANCAM/ROB STEP increased estimate for quarter ending 03/98 from $0.29 to $0.33 on 01/08/98 AGPH: NATNBK MONT.SEC has reiterated estimate for fiscal year ending 06/98 of $0.87 on 01/08/98 AGPH: NATNBK MONT.SEC has reiterated estimate for quarter ending 12/97 of $0.15 on 01/08/98 The Zacks consensus estimate of earnings per share for AGPH's 12/97 quarter is $0.14.